{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:16:46Z","timestamp":1788304606570,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":64,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_5","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:24Z","timestamp":1788302964000},"page":"91-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mouse Model of Hemolytic Disease of the Fetus and Newborn"],"prefix":"10.1007","author":[{"given":"Hirotomo","family":"Nakahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasikala","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"5_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-3476(32)80057-0","volume":"1","author":"LK Diamond","year":"1932","unstructured":"Diamond LK, Blackfan KD, Baty JM (1932) Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatr 1(3):269\u2013309","journal-title":"J Pediatr"},{"issue":"6","key":"5_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0002-9378(41)90260-0","volume":"42","author":"P Levine","year":"1941","unstructured":"Levine P et al (1941) The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 42(6):925\u2013937","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"5_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00043426-200111000-00017","volume":"23","author":"JL Naiman","year":"2001","unstructured":"Naiman JL (2001) On Dr. Louis K. Diamond's 1932 article and subsequent contributions to erythroblastosis fetalis. J Pediatr Hematol Oncol 23(8):550\u2013553","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"5_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","volume":"25","author":"JR Storry","year":"2009","unstructured":"Storry JR, Olsson ML (2009) The ABO blood group system revisited: a review and update. Immunohematology 25(2):48\u201359","journal-title":"Immunohematology"},{"issue":"4","key":"5_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ajt.2022.12.017","volume":"23","author":"A Joseph","year":"2023","unstructured":"Joseph A et al (2023) ABO Genotyping finds more A(2) to B kidney transplant opportunities than lectin-based subtyping. Am J Transplant 23(4):512\u2013519","journal-title":"Am J Transplant"},{"issue":"1","key":"5_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105798","volume":"26","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) ABO blood group antigens and differential glycan expression: perspective on the evolution of common human enzyme deficiencies. iScience 26(1):105798","journal-title":"iScience"},{"issue":"7","key":"5_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104482","volume":"25","author":"SC Wu","year":"2022","unstructured":"Wu SC et al (2022) Innate immune Galectin-7 specifically targets microbes that decorate themselves in blood group-like antigens. iScience 25(7):104482","journal-title":"iScience"},{"issue":"4","key":"5_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101704","volume":"298","author":"AV Blenda","year":"2022","unstructured":"Blenda AV et al (2022) Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. J Biol Chem 298(4):101704","journal-title":"J Biol Chem"},{"issue":"5","key":"5_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100747","volume":"23","author":"HM Jan","year":"2024","unstructured":"Jan HM et al (2024) Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain. Mol Cell Proteomics 23(5):100747","journal-title":"Mol Cell Proteomics"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pathol-042320-110411","volume":"18","author":"CM Arthur","year":"2023","unstructured":"Arthur CM, Stowell SR (2023) The development and consequences of red blood cell alloimmunization. Annu Rev Pathol 18:537\u2013564","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"5_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","volume":"43","author":"J Bowman","year":"2003","unstructured":"Bowman J (2003) Thirty-five years of Rh prophylaxis. Transfusion 43(12):1661\u20131666","journal-title":"Transfusion"},{"issue":"2","key":"5_CR12","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","volume":"130","author":"Practice Bulletin No","year":"2017","unstructured":"Practice Bulletin No (2017) 181: prevention of Rh D alloimmunization. Obstet Gynecol 130(2):e57\u2013e70","journal-title":"Obstet Gynecol"},{"issue":"3","key":"5_CR13","doi-asserted-by":"publisher","first-page":"227 e1","DOI":"10.1016\/j.ajog.2019.05.019","volume":"221","author":"GHA Visser","year":"2019","unstructured":"Visser GHA et al (2019) The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action. Am J Obstet Gynecol 221(3):227 e1\u2013227 e4","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"5_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/pr.2013.208","volume":"74 Suppl 1","author":"VK Bhutani","year":"2013","unstructured":"Bhutani VK et al (2013) Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 74 Suppl 1(Suppl 1):86\u2013100","journal-title":"Pediatr Res"},{"issue":"2","key":"5_CR15","doi-asserted-by":"publisher","first-page":"F84","DOI":"10.1136\/adc.2009.181172","volume":"96","author":"A Zipursky","year":"2011","unstructured":"Zipursky A, Paul VK (2011) The global burden of Rh disease. Arch Dis Child Fetal Neonatal Ed 96(2):F84\u2013F85","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"10429","key":"5_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(23)01888-3","volume":"403","author":"E Verweij","year":"2024","unstructured":"Verweij E et al (2024) Monoclonal RhD prophylaxis: high time to evaluate efficacy. Lancet 403(10429):806\u2013807","journal-title":"Lancet"},{"key":"5_CR17","doi-asserted-by":"crossref","unstructured":"(2018) ACOG Practice Bulletin No. 192: Management of alloimmunization during pregnancy. Obstet Gynecol 131(3):e82\u2013e90","DOI":"10.1097\/AOG.0000000000002528"},{"issue":"2","key":"5_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2023.100203","volume":"3","author":"D Yu","year":"2023","unstructured":"Yu D et al (2023) Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010. AJOG Glob Rep 3(2):100203","journal-title":"AJOG Glob Rep"},{"key":"5_CR19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012241","volume-title":"Maternal red blood cell alloimmunization prevalence in the United States","author":"RP Sugrue","year":"2024","unstructured":"Sugrue RP et al (2024) Maternal red blood cell alloimmunization prevalence in the United States. Blood Adv"},{"issue":"6","key":"5_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MOH.0000000000000374","volume":"24","author":"Y Cruz-Leal","year":"2017","unstructured":"Cruz-Leal Y, Marjoram D, Lazarus AH (2017) Prevention of hemolytic disease of the fetus and newborn: what have we learned from animal models? Curr Opin Hematol 24(6):536\u2013543","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"5_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","volume":"30","author":"JE Hendrickson","year":"2016","unstructured":"Hendrickson JE, Delaney M (2016) Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev 30(4):159\u2013164","journal-title":"Transfus Med Rev"},{"issue":"2","key":"5_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S0022172400014376","volume":"47","author":"DH Heard","year":"1949","unstructured":"Heard DH, Hinde IT, Mynors LS (1949) An experimental study of haemolytic disease of the newborn due to isoimmunization of pregnancy. J Hyg (Lond) 47(2):119\u2013131","journal-title":"J Hyg (Lond)"},{"issue":"5","key":"5_CR23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0002-9378(98)70159-0","volume":"179","author":"KJ Moise Jr","year":"1998","unstructured":"Moise KJ Jr et al (1998) An animal model for hemolytic disease of the fetus or newborn in New Zealand white and New Zealand red rabbits: newborn effects. Am J Obstet Gynecol 179(5):1353\u20131358","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0002-9378(95)90168-X","volume":"173","author":"KJ Moise Jr","year":"1995","unstructured":"Moise KJ Jr et al (1995) An animal model for hemolytic disease of the fetus and newborn. I. Alloimmunization techniques. Am J Obstet Gynecol 173(1):51\u201355","journal-title":"Am J Obstet Gynecol"},{"issue":"3 Pt 1","key":"5_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/0002-9378(95)90334-8","volume":"173","author":"KJ Moise Jr","year":"1995","unstructured":"Moise KJ Jr et al (1995) An animal model for hemolytic disease of the fetus and newborn. II. Fetal effects in New Zealand rabbits. Am J Obstet Gynecol 173(3 Pt 1):747\u2013753","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.97.1.33","volume":"97","author":"A Kellner","year":"1953","unstructured":"Kellner A, Hedal EF (1953) Experimental erythroblastosis fetalis in rabbits. I. Characterization of a pair of allelic blood group factors and their specific immune isoantibodies. J Exp Med 97(1):33\u201349","journal-title":"J Exp Med"},{"issue":"1","key":"5_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.97.1.51","volume":"97","author":"A Kellner","year":"1953","unstructured":"Kellner A, Hedal EF (1953) Experimental erythroblastosis fetalis in rabbits. II. The passage of blood group antigens and their specific isoantibodies across the placenta. J Exp Med 97(1):51\u201360","journal-title":"J Exp Med"},{"issue":"11","key":"5_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080460","volume":"8","author":"D Goossens","year":"2013","unstructured":"Goossens D et al (2013) Mice expressing RHAG and RHD human blood group genes. PLoS One 8(11):e80460","journal-title":"PLoS One"},{"key":"5_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/470242","volume":"2014","author":"L Bernardo","year":"2014","unstructured":"Bernardo L et al (2014) RhD specific antibodies are not detectable in HLA-DRB1(*)1501 mice challenged with human RhD positive erythrocytes. Adv Hematol 2014:470242","journal-title":"Adv Hematol"},{"issue":"6","key":"5_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MOH.0b013e328311f40a","volume":"15","author":"EA Hod","year":"2008","unstructured":"Hod EA, Zimring JC, Spitalnik SL (2008) Lessons learned from mouse models of hemolytic transfusion reactions. Curr Opin Hematol 15(6):601\u2013605","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"5_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","volume":"106","author":"JC Zimring","year":"2005","unstructured":"Zimring JC et al (2005) Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 106(3):1105\u20131112","journal-title":"Blood"},{"issue":"6","key":"5_CR32","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","volume":"110","author":"JC Zimring","year":"2007","unstructured":"Zimring JC et al (2007) Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood 110(6):2201\u20132208","journal-title":"Blood"},{"issue":"3","key":"5_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","volume":"112","author":"EA Hod","year":"2008","unstructured":"Hod EA et al (2008) Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 112(3):891\u2013894","journal-title":"Blood"},{"key":"5_CR34","doi-asserted-by":"crossref","unstructured":"Mener A et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22)","DOI":"10.1172\/jci.insight.121631"},{"issue":"11","key":"5_CR35","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","volume":"101","author":"A Arneja","year":"2016","unstructured":"Arneja A et al (2016) Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica 101(11):e440\u2013e444","journal-title":"Haematologica"},{"key":"5_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.972723","volume":"13","author":"A Qiu","year":"2022","unstructured":"Qiu A et al (2022) FcgammaRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Front Immunol 13:972723","journal-title":"Front Immunol"},{"issue":"4","key":"5_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4049\/jimmunol.2100784","volume":"208","author":"A Soldatenko","year":"2022","unstructured":"Soldatenko A et al (2022) Innate and adaptive immunity to transfused allogeneic RBCs in mice requires MyD88. J Immunol 208(4):991\u2013997","journal-title":"J Immunol"},{"issue":"10","key":"5_CR38","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3324\/haematol.2023.282815","volume":"108","author":"TA Thomas","year":"2023","unstructured":"Thomas TA et al (2023) Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica 108(10):2639\u20132651","journal-title":"Haematologica"},{"key":"5_CR39","doi-asserted-by":"crossref","unstructured":"Jash A et al (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest 134(8)","DOI":"10.1172\/JCI167665"},{"issue":"7","key":"5_CR40","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","volume":"198","author":"CM Arthur","year":"2017","unstructured":"Arthur CM et al (2017) Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol 198(7):2671\u20132680","journal-title":"J Immunol"},{"issue":"21","key":"5_CR41","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653","journal-title":"Blood"},{"issue":"8","key":"5_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE et al (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138(8):706\u2013721","journal-title":"Blood"},{"issue":"12","key":"5_CR43","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP et al (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098","journal-title":"Blood"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"1475470","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP et al (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"issue":"14","key":"5_CR45","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM et al (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood 127(14):1823\u20131827","journal-title":"Blood"},{"issue":"23","key":"5_CR46","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"9","key":"5_CR47","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317","journal-title":"Blood"},{"issue":"6","key":"5_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.111172","volume":"85","author":"DK Newman","year":"2024","unstructured":"Newman DK, Newman PJ (2024) Antigen-specific immunotherapy for platelet alloimmune disorders. Hum Immunol 85(6):111172","journal-title":"Hum Immunol"},{"issue":"20","key":"5_CR49","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood.2022015666","volume":"140","author":"H Zhi","year":"2022","unstructured":"Zhi H et al (2022) Prophylactic administration of HPA-1a-specific antibodies prevents fetal\/neonatal alloimmune thrombocytopenia in mice. Blood 140(20):2146\u20132153","journal-title":"Blood"},{"issue":"7","key":"5_CR50","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","volume":"52","author":"H Tiller","year":"2012","unstructured":"Tiller H et al (2012) Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 52(7):1446\u20131457","journal-title":"Transfusion"},{"issue":"18","key":"5_CR51","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1182\/blood.2021011131","volume":"138","author":"X Xu","year":"2021","unstructured":"Xu X et al (2021) Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model. Blood 138(18):1757\u20131767","journal-title":"Blood"},{"issue":"18","key":"5_CR52","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/bloodadvances.2021004371","volume":"5","author":"H Zhi","year":"2021","unstructured":"Zhi H et al (2021) Preclinical evaluation of immunotherapeutic regimens for fetal\/neonatal alloimmune thrombocytopenia. Blood Adv 5(18):3552\u20133562","journal-title":"Blood Adv"},{"issue":"11","key":"5_CR53","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1172\/JCI57850","volume":"121","author":"C Li","year":"2011","unstructured":"Li C et al (2011) The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. J Clin Invest 121(11):4537\u20134547","journal-title":"J Clin Invest"},{"issue":"18","key":"5_CR54","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","volume":"116","author":"P Chen","year":"2010","unstructured":"Chen P et al (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal fc receptor in the pathogenesis and therapy. Blood 116(18):3660\u20133668","journal-title":"Blood"},{"issue":"8","key":"5_CR55","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122(8):1494\u20131504. https:\/\/doi.org\/10.1182\/blood-2013-03-488874","journal-title":"Blood"},{"issue":"12","key":"5_CR56","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1537-2995.2012.03641.x","volume":"52","author":"NH Smith","year":"2012","unstructured":"Smith NH et al (2012) Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion 52(12):2620\u20132630","journal-title":"Transfusion"},{"key":"5_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A et al (2021) Antibodies to low-copy number RBC alloantigen convert a tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol 12:629608","journal-title":"Front Immunol"},{"issue":"21","key":"5_CR58","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","volume":"2","author":"CL Maier","year":"2018","unstructured":"Maier CL et al (2018) Antibody-mediated immune suppression by antigen modulation is antigen-specific. Blood Adv 2(21):2986\u20133000","journal-title":"Blood Adv"},{"issue":"1","key":"5_CR59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/trf.14939","volume":"59","author":"A Mener","year":"2019","unstructured":"Mener A et al (2019) Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcgamma receptors in mice. Transfusion 59(1):371\u2013384","journal-title":"Transfusion"},{"issue":"1","key":"5_CR60","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/trf.17197","volume":"63","author":"A Jash","year":"2023","unstructured":"Jash A et al (2023) The role of RBC antigen transgene integration sites on RBC biology in mice. Transfusion 63(1):239\u2013248","journal-title":"Transfusion"},{"issue":"3","key":"5_CR61","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.4049\/jimmunol.1700401","volume":"199","author":"DR Gibb","year":"2017","unstructured":"Gibb DR et al (2017) Type I IFN is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice. J Immunol 199(3):1041\u20131050","journal-title":"J Immunol"},{"issue":"1","key":"5_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tmrv.2022.12.009","volume":"37","author":"SR Patel","year":"2023","unstructured":"Patel SR, Maier CL, Zimring JC (2023) Alloantigen copy number as a critical factor in RBC alloimmunization. Transfus Med Rev 37(1):21\u201326","journal-title":"Transfus Med Rev"},{"issue":"2","key":"5_CR63","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM et al (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5(2):527\u2013538","journal-title":"Blood Adv"},{"key":"5_CR64","doi-asserted-by":"crossref","unstructured":"Lopez ME (2012) A auick, no frills approach to mouse genotyping. Bio Protoc 2(15)","DOI":"10.21769\/BioProtoc.244"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:49:25Z","timestamp":1788302965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}